New York, NY (PRWEB) August 14, 2012
Protein biomarkers have been hailed as vital stepping stones in the race to personalize medicine. But many hurdles remain to be cleared before their application becomes routine. Currently, protein biomarkers have proven useful in drug discovery and development, as tools for target discovery and evaluation of a drug’s mechanism of action, and in therapies for prevention, early detection, diagnosis, and treatment of disease. Although single markers are in use, more widespread adoption will probably require a multiplexed panel capable of detecting and measuring biomarkers accurately, inexpensively, and easily in biological samples that are highly complex.
What You Will Learn:
This free webinar, “Tackling the Challenges Involved with Protein Biomarkers,” brings together two experts who will discuss new approaches for dealing with everything from enriching the target protein molecule to methods now in use for isolating and detecting molecules, for biomarker discovery and applications.
Before a biomarker can be put to use, it must undergo several stages of confirmation, validation, and qualification depending on its intended use. Sample preparation involves many challenges. Once an appropriate method has been chosen to isolate and measure the biomarker or pattern of markers, technical parameters of the assay must be defined to establish its sensitivity, specificity, reproducibility, and reliability.
To take advantage of this FREE webinar and experts' advice, click here: http://www.the-scientist.com/2012/07/05/protein-biomarkers/
Who should attend?
This webinar is designed for lab managers, directors, scientists, technicians, analysts, and engineers interested in expanding their current knowledge and/or wishing to develop an understanding about:
This session is slated for 90 minutes and will be divided into a 60-minute presentation with a 30-minute open forum for a live Q&A, all using the GoToWebinar platform. After the session, all attendees will receive links to the presentation materials posted on the-scientist.com.
Dr. Katherine Williams is an assistant professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of California, San Francisco, and is a senior member of the Sandler-Moore Mass Spectrometry Core Facility. Her research program is focused on using proteomics for biomarker discovery and verification in a wide range of human disease biology.
Dr. Lance Liotta is a tenured professor at George Mason University in the Department of Systems Biology, College of Science. He was one of the first scientists to investigate the process of tumor invasion and metastasis at the molecular level. Liotta has invented and patented technologies in the fields of diagnostics, nanotechnology (hydrogel nanoparticles for biomarker harvesting), microdissection (laser-capture microdissection), and proteomics (reverse-phase protein microarrays), all of which have been used to make broad discoveries in cancer biology and cancer therapy.
When: Thursday August 16, 2012
Where: Live Web Event via GoToWebinar Platform; a link will be provided after free registration at: Register Now!
Time: 12:30 p.m. to 2:00 p.m. EDT
Sponsored by: Shimadzu – Excellence in Science
About The Scientist:
The Scientist has informed and entertained life science professionals around the world for more than 25 years. The title provides innovative print and online coverage of the latest innovations in life science research and industry developments including trends in research, new technology, news, business and careers. We reach leading researchers in academia and industry who are interested in maintaining a broad view of the life sciences by reading insightful articles that are current, concise, accurate, and entertaining. For more information about The Scientist, visit http://www.the-scientist.com.